Saturday , July 31 2021
Home / Alberto Mingardi /Boris Johnson’s two cheers for capitalism

Boris Johnson’s two cheers for capitalism

Summary:
Boris Johnson saluted fast development of COVID vaccines as a triumph of capitalism, even though he associated, somehow infelicitously, capitalism with greed (on the point, read Eamonn Butler). It is a bit bizarre that Johnson on the one hand sees R&D as a success of the market system, but at the same time wants to put more government money in it- committing £800 million to a new agency called ARIA (the Advanced Research and Invention Agency.) Johnson is never particularly bothered by consistency, but praising capitalism for its ability to develop and supply new highly complex goods like vaccines, and then calling for more government intervention in R&D seems a bit too much, even for him. Johnson should perhaps listen to Terence Kealey, who advises him to stop

Topics:
Alberto Mingardi considers the following as important: , , , ,

This could be interesting, too:

Don Boudreaux writes Some Covid Links

Pierre Lemieux writes Two Weaknesses of Socialism

David Henderson writes EconVersation with Dan Sutter of Troy University

Thomas Firey writes The Housing Misery of U.S. Lumber (and Other) Tariffs

Boris Johnson saluted fast development of COVID vaccines as a triumph of capitalism, even though he associated, somehow infelicitously, capitalism with greed (on the point, read Eamonn Butler).

It is a bit bizarre that Johnson on the one hand sees R&D as a success of the market system, but at the same time wants to put more government money in it- committing £800 million to a new agency called ARIA (the Advanced Research and Invention Agency.) Johnson is never particularly bothered by consistency, but praising capitalism for its ability to develop and supply new highly complex goods like vaccines, and then calling for more government intervention in R&D seems a bit too much, even for him.

Boris Johnson’s two cheers for capitalism

Johnson should perhaps listen to Terence Kealey, who advises him to stop funding research, if he really wants to promote it.

In this piece, Terence makes sense of another interesting oddity. The UK has been disastrous in managing the Covid-19 pandemic from all points of view: a very high death toll, very strict lockdowns, little respect for the rule of law, and myriad failures along the way (consider the different experiments in massive testing that never really took off). But all of that has been redeemed by a remarkable vaccination rollout, which is likely to save Johnson’s reputation- at least for a while.

How come a government that has performed rather badly on most Covid-19 related matters was that good on the vaccine rollout? Terence’s answer is Catherine Bingham, who chairs the UK Government Vaccine Taskforce and previously worked at Schroder Ventures specializing in biotechnology. As Terence writes:

The only bright spark in the last 12 months in the UK, as 126,000 of our fellow citizens have died prematurely, as the economy and our social lives have tanked, and as the Government has been repeatedly exposed as incompetent, has been the vaccine programme run by Kate Bingham.

She has been to vaccines what Lord Beaverbrook, the newspaper proprietor, was to fighter production during the Battle of Britain. In May 1940 Churchill recognised the public sector could never supply Fighter Command with enough fighters, so he installed Beaverbrook as the Minister of Aircraft Production; and Beaverbrook – harnessing the entrepreneurial flair of the private sector – performed such wonders that the RAF was never short of aircraft. Pilots, yes; aircraft, no.

But for Bingham, Britain’s vaccine response would have been like the EU’s: cautious, cost-obsessed, legalistic and slow. But Bingham was imported from the private sector, were she’d worked as a venture capitalist and where she’d learnt to be bold, cost-effective, purposeful and fast.

Alberto Mingardi
Mingardi, one of the rising stars of European libertarianism, is the founder and Director General of the Italian free-market think tank, Instituto Bruno Leoni. His areas of interest include the history of economic thought and antitrust and healthcare systems. He is particularly well known for popularizing the work of past scholars under-appreciated by today’s libertarians. Currently an adjunct scholar at the Cato Institute, Mingardi has also worked with the Heritage Foundation, the Atlas Economic Research Foundation, the Acton Institute, and the Centre for a New Europe.

Leave a Reply

Your email address will not be published. Required fields are marked *